COVID-19 Induced Coagulopathy: A Common Challenge in Intensive Care Units
International Pharmacy Acta · 03.11.2025
DOI: 10.22037/ipa.v8i1.47874 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Pharmacy Acta, erschienen am 03.11.2025. Verfasst von Shafagh Aliasgarzadeh und 7 weiteren Autor:innen.
Themen: Intensivpflege
Abstract (Originalsprache)
The ongoing Coronavirus disease (COVID-19) pandemic has caused widespread global transmission. Hemostatic disorders are known complications of the disease, leading to blood clots and bleeding. These disorders are associated with high mortality rates. This study aimed to determine the prevalence of hemostatic disorders among COVID-19 patients admitted to intensive care units (ICUs). During a one-year period, an observational cross-sectional study was conducted on COVID-19 patients admitted to Imam Khomeini Hospital in Ardabil. This study assessed 911 patients with COVID-19 who were hospitalized in the ICU, aged of 62.26 years on average, of which 54.3% were males. The mortality rate was 52.3% mortality rate. 8.6% of patients had thromboembolic or bleeding disorders. Most cases involved bleeding (5.9%), followed by DVT (2.1%) and PTE (0.8%). In our study, we found that patients with a history of thromboembolism (P-Value = 0.000), cancer (P-Value = 0.000), cardiovascular disease (P-Value = 0.025), hypertension (P-Value = 0.030), and rheumatological diseases (P-Value = 0.035) had significantly higher rates of thromboembolism and hemorrhagic events. The prevalence of thromboembolic and bleeding disorders was also significantly higher in patients with elevated LDH (0.001), INR (0.014), D-dimer (0.015), CRP (0.039), and BUN (0.046) levels. Our study elucidates three critical aspects of COVID-19-associated coagulopathy in patients admitted to the intensive care unit. The prevalence of hemostatic disorders was notably 8.6%, with bleeding complications being the most common at 5.9%. Significant associations were observed between thromboembolic events and pre-existing conditions, particularly prior thromboembolism and cancer. Laboratory markers, such as elevated levels of LDH, D-dimer, and INR, possess prognostic significance for identifying patients at high risk.
Schlagwörter
Zitieren
APA
Aliasgarzadeh, S., Mousavi, S. R., Mirak, S. M., Mehr, A. D., Aslani, M. R., Iranijam, E., Javaheri, N., & Farhadi, G. (2025). COVID-19 Induced Coagulopathy: A Common Challenge in Intensive Care Units. International Pharmacy Acta. https://doi.org/10.22037/ipa.v8i1.47874
Vancouver
Aliasgarzadeh S, Mousavi SR, Mirak SM, Mehr AD, Aslani MR, Iranijam E, et al. COVID-19 Induced Coagulopathy: A Common Challenge in Intensive Care Units. International Pharmacy Acta. 2025. doi:10.22037/ipa.v8i1.47874
BibTeX
@article{Aliasgarzadeh2025,
author = {Aliasgarzadeh, Shafagh and Mousavi, Seyed Reza and Mirak, Sevda Mikaeili and Mehr, Amin Danande and Aslani, Mohammad Reza and Iranijam, Effat and Javaheri, Nazli and Farhadi, Ghazaleh},
title = {COVID-19 Induced Coagulopathy: A Common Challenge in Intensive Care Units},
journal = {International Pharmacy Acta},
year = {2025},
doi = {10.22037/ipa.v8i1.47874}
}
EUVIMED